BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu HJ, Hoppe BS, Flampouri S, Louis D, Pirris J, Nichols RC, Henderson RH, Mercado CE. Rationale and early outcomes for the management of thymoma with proton therapy. Transl Lung Cancer Res. 2018;7:106-113. [PMID: 29876309 DOI: 10.21037/tlcr.2018.04.06] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Rico M, Flamarique S, Casares C, García T, López M, Martínez M, Serrano J, Blanco M, Hernanz R, de Ingunza-Barón L, Marcos FJ, Couñago F. GOECP/SEOR radiotherapy guidelines for thymic epithelial tumours. World J Clin Oncol 2021; 12(4): 195-216 [PMID: 33959475 DOI: 10.5306/wjco.v12.i4.195] [Reference Citation Analysis]
2 Franceschini D, Cozzi L, Loi M, Franzese C, Reggiori G, Mancosu P, Clivio A, Fogliata A, Scorsetti M. Volumetric modulated arc therapy vs intensity-modulated proton therapy in the postoperative irradiation of thymoma. J Cancer Res Clin Oncol. 2020;146:2267-2276. [PMID: 32514629 DOI: 10.1007/s00432-020-03281-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
3 Loap P, Vitolo V, Barcellini A, De Marzi L, Mirandola A, Fiore MR, Vischioni B, Jereczek-Fossa BA, Girard N, Kirova Y, Orlandi E. Hadrontherapy for Thymic Epithelial Tumors: Implementation in Clinical Practice. Front Oncol 2021;11:738320. [PMID: 34707989 DOI: 10.3389/fonc.2021.738320] [Reference Citation Analysis]
4 Loap P, Scher N, Goudjil F, Kirova Y, Girard N, Cao KI. Proton Beam Therapy for Thymic Carcinoma with Pericardial Involvement. Int J Part Ther 2021;7:65-70. [PMID: 33604417 DOI: 10.14338/IJPT-20-00023.1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 König L, Hörner-rieber J, Forsthoefel M, Haering P, Meixner E, Eichkorn T, Krämer A, Mielke T, Tonndorf-martini E, Haefner MF, Debus J, Lischalk JW. Secondary Malignancy Risk Following Proton vs. X-ray Radiotherapy of Thymic Epithelial Tumors: A Comparative Modeling Study of Thoracic Organ-Specific Cancer Risk. Cancers 2022;14:2409. [DOI: 10.3390/cancers14102409] [Reference Citation Analysis]
6 Sharma UC, Sonkawade SD, Baird A, Chen M, Xu S, Sexton S, Singh AK, Groman A, Turowski SG, Spernyak JA, Mahajan SD, Pokharel S. Effects of a novel peptide Ac-SDKP in radiation-induced coronary endothelial damage and resting myocardial blood flow. Cardiooncology 2018;4:8. [PMID: 31057947 DOI: 10.1186/s40959-018-0034-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
7 Ratosa I, Ivanetic Pantar M. Cardiotoxicity of mediastinal radiotherapy. Rep Pract Oncol Radiother 2019;24:629-43. [PMID: 31719801 DOI: 10.1016/j.rpor.2019.09.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
8 McGunigal M, Margolis M, Forsthoefel M, Singh T, Amarell K, Deblois D, Campbell L, Kim C, Liu S, Bergquist PJ, Debrito P, Collins BT, Giaccone G, Lischalk JW. Thymic malignancies treated with active scanning proton beam radiation and Monte Carlo planning: early clinical experience. Acta Oncol 2021;60:649-52. [PMID: 33629926 DOI: 10.1080/0284186X.2021.1887516] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Loap P, Tkatchenko N, Goudjil F, Ribeiro M, Baron B, Fourquet A, Kirova Y. Cardiac substructure exposure in breast radiotherapy: a comparison between intensity modulated proton therapy and volumetric modulated arc therapy. Acta Oncol 2021;60:1038-44. [PMID: 33788665 DOI: 10.1080/0284186X.2021.1907860] [Reference Citation Analysis]
10 Patel NV, Yu NY, Koroulakis A, Diwanji T, Sawant A, Sio TT, Mohindra P. Proton therapy for thoracic malignancies: a review of oncologic outcomes. Expert Rev Anticancer Ther 2021;21:177-91. [PMID: 33118427 DOI: 10.1080/14737140.2021.1844567] [Reference Citation Analysis]
11 Algranati C, Strigari L. Imaging Strategies in Proton Therapy for Thoracic Tumors: A Mini Review. Front Oncol 2022;12:833364. [DOI: 10.3389/fonc.2022.833364] [Reference Citation Analysis]
12 Mercado CE, Hartsell WF, Simone CB, Tsai HK, Vargas CE, Zhu HJ, Henderson RH, Zeng J, Larson GL, Hoppe BS. Proton therapy for thymic malignancies: multi-institutional patterns-of-care and early clinical outcomes from the proton collaborative group and the university of Florida prospective registries. Acta Oncologica 2019;58:1036-40. [DOI: 10.1080/0284186x.2019.1575981] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]